Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Curr Opin Ophthalmol. 2014 May;25(3):186–190. doi: 10.1097/ICU.0000000000000046

Table 1. Nutrient formulations included in the primary randomization of the AREDS2.

Study Formulation Daily Dose
Placebo ---
Lutein/Zeaxanthin 10 mg/2 mg
DHA/EPA 350 mg/650 mg
Lutein/Zeaxanthin + DHA/EPA 10 mg/2 mg + 350 mg/650 mg

DHA: docosahexaenoic acid, EPA: eicosapentaenoic acid